Nucleoside reverse transcriptase inhibitors (NRTIs)

GX EJ7 Pill - gray four-sided, 17mm

Generic Name: lamivudine

Pill with imprint GX EJ7 is Gray, Four-sided and has been identified as Epivir 300 mg. It is supplied by GlaxoSmithKline.

Epivir is used in the treatment of Hepatitis B; HIV Infection; Occupational Exposure; Nonoccupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Epivir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Epivir (Lamivudine [ la-miv-ue-deen ])-GX EJ7-300 mg-Gray-Four-sided
Epivir (Lamivudine [ la-miv-ue-deen ])-GX EJ7-300 mg-Gray-Four-sided
Epivir (Lamivudine [ la-miv-ue-deen ])-GX EJ7-300 mg-Gray-Four-sided
Epivir (Lamivudine [ la-miv-ue-deen ])-GX EJ7-300 mg-Gray-Four-sided
Epivir (Lamivudine [ la-miv-ue-deen ])-GX EJ7-300 mg-Gray-Four-sided
Epivir (Lamivudine [ la-miv-ue-deen ])-GX EJ7-300 mg-Gray-Four-sided

Epivir
Generic Name: lamivudine [ la-miv-ue-deen ]
Imprint: GX EJ7
Strength: 300 mg
Color: Gray
Size: 17.00 mm
Shape: Four-sided
Availability: Prescription only
Drug Class: Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00173-0714 (Discontinued)
Inactive Ingredients: Ferrosoferric oxide, Hypromelloses, Magnesium stearate, Microcrystalline cellulose, Polyethylene glycol, Polysorbate 80, Sodium starch glycolate type A potato, Titanium dioxide,
Latest News
Related Drugs